Caricamento...
Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France
BACKGROUND AND AIMS: The heterogeneous nature of breast cancer can make decisions on adjuvant chemotherapy following surgical resection challenging. Oncotype DX is a validated gene expression profiling test that predicts the likelihood of adjuvant chemotherapy benefit in early-stage breast cancer. T...
Salvato in:
| Pubblicato in: | PLoS One |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472722/ https://ncbi.nlm.nih.gov/pubmed/26086912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128880 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|